Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Floris J Pos

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2021
Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trialVeerle H Groen, Nicolaas P A Zuithoff, Marcel van Schie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 30, 2021
Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trialVeerle H Groen, Marcel van Schie, Nicolaas P A Zuithoff, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2015
Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validationPeter Steenbergen, Karin Haustermans, Evelyne Lerut, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II TrialHielke M de Vries, Tynisha S Rafael, Alberto Gil-Jimenez, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2026
Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trialJoost Surewaard, Ruben Bosschaert, Herbert Beemster, et al.
International Journal of Radiation Oncology, Biology, Physics|August 26, 2023
Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver VariabilityKobika Sritharan, Hafid Akhiat, Declan Cahill, et al.
European Urology Focus|November 22, 2019
Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based StudyBarbara Lily Thérèse Rijksen, Floris J Pos, Maarten C C M Hulshof, et al.
The Lancet. Oncology|February 2, 2025
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.
The Lancet. Oncology|March 20, 2025
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortiumAmar U Kishan, Yilun Sun, Alison C Tree, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2023
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the ProstateSoumyajit Roy, Tahmineh Romero, Jeff M Michalski, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2021
Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trialVeerle H Groen, Nicolaas P A Zuithoff, Marcel van Schie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 30, 2021
Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trialVeerle H Groen, Marcel van Schie, Nicolaas P A Zuithoff, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2015
Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validationPeter Steenbergen, Karin Haustermans, Evelyne Lerut, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II TrialHielke M de Vries, Tynisha S Rafael, Alberto Gil-Jimenez, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2026
Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trialJoost Surewaard, Ruben Bosschaert, Herbert Beemster, et al.
International Journal of Radiation Oncology, Biology, Physics|August 26, 2023
Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver VariabilityKobika Sritharan, Hafid Akhiat, Declan Cahill, et al.
European Urology Focus|November 22, 2019
Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based StudyBarbara Lily Thérèse Rijksen, Floris J Pos, Maarten C C M Hulshof, et al.
The Lancet. Oncology|February 2, 2025
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.
The Lancet. Oncology|March 20, 2025
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortiumAmar U Kishan, Yilun Sun, Alison C Tree, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2023
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the ProstateSoumyajit Roy, Tahmineh Romero, Jeff M Michalski, et al.
Pageof 9